3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
7
Phase 2
5
Phase 2/3
2
Phase 1/2
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Carcinoma, Non-Small-Cell Lung
47
Prostatic Neoplasms
33
Breast Neoplasms
23
Stomach Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
15
Lung Neoplasms
15
Esophageal Neoplasms
13
Neoplasm Metastasis
11
Sarcoma
9
Neoplasms
9
Colorectal Neoplasms
7
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Carcinoma, Renal Cell
6
Melanoma
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms, Male
4
Salivary Gland Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
3
Pancreatic Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
3
Leiomyosarcoma
3
Inflammatory Breast Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Squamous Cell
3
Interventions
Trastuzumab
4
pertuzumab
2
Docetaxel
2
palbociclib
1
Protons
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Fluorodeoxyglucose F18
1
Enfuvirtide
1
Doxorubicin
1
Cyclophosphamide
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
HER2-positive Breast Cancer
×
Docetaxel
×
Clear all
NCT02379585
2018-04-24
STEFNE
Western Regional Medical Center
Phase 1/2
Terminated
8 enrolled
1 chart
NCT02345772
2018-02-20
Neohttp
Western Regional Medical Center
Phase 1/2
Terminated
4 enrolled
1 chart